BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 9494707)

  • 1. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia).
    Young AH; Sharpe M; Clements A; Dowling B; Hawton KE; Cowen PJ
    Biol Psychiatry; 1998 Feb; 43(3):236-7. PubMed ID: 9494707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome.
    Jerjes WK; Cleare AJ; Wessely S; Wood PJ; Taylor NF
    J Affect Disord; 2005 Aug; 87(2-3):299-304. PubMed ID: 15922454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome.
    Jerjes WK; Taylor NF; Peters TJ; Wessely S; Cleare AJ
    Psychosom Med; 2006; 68(4):578-82. PubMed ID: 16868267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
    Inder WJ; Prickett TC; Mulder RT
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A; Hudson M; Jerjes W; Cleare AJ
    Psychosom Med; 2005; 67(3):433-40. PubMed ID: 15911907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome.
    Jerjes WK; Peters TJ; Taylor NF; Wood PJ; Wessely S; Cleare AJ
    J Psychosom Res; 2006 Feb; 60(2):145-53. PubMed ID: 16439267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
    Van Den Eede F; Moorkens G; Hulstijn W; Van Houdenhove B; Cosyns P; Sabbe BG; Claes SJ
    Psychol Med; 2008 Jul; 38(7):963-73. PubMed ID: 17803834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.
    Tanriverdi F; Karaca Z; Unluhizarci K; Kelestimur F
    Stress; 2007 Mar; 10(1):13-25. PubMed ID: 17454963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.
    Gaab J; Engert V; Heitz V; Schad T; Schürmeyer TH; Ehlert U
    J Psychosom Res; 2004 Apr; 56(4):419-24. PubMed ID: 15094026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome.
    Van Den Eede F; Moorkens G; Van Houdenhove B; Cosyns P; Claes SJ
    Neuropsychobiology; 2007; 55(2):112-20. PubMed ID: 17596739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HPA axis and the genesis of chronic fatigue syndrome.
    Cleare AJ
    Trends Endocrinol Metab; 2004 Mar; 15(2):55-9. PubMed ID: 15036250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome.
    Jerjes WK; Taylor NF; Wood PJ; Cleare AJ
    Psychoneuroendocrinology; 2007 Feb; 32(2):192-8. PubMed ID: 17276605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimentally challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis.
    Dekkers JC; Geenen R; Godaert GL; Glaudemans KA; Lafeber FP; van Doornen LJ; Bijlsma JW
    J Rheumatol; 2001 Jul; 28(7):1496-504. PubMed ID: 11469453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome.
    Crofford LJ; Young EA; Engleberg NC; Korszun A; Brucksch CB; McClure LA; Brown MB; Demitrack MA
    Brain Behav Immun; 2004 Jul; 18(4):314-25. PubMed ID: 15157948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical burnout is not reflected in the cortisol awakening response, the day-curve or the response to a low-dose dexamethasone suppression test.
    Mommersteeg PM; Heijnen CJ; Verbraak MJ; van Doornen LJ
    Psychoneuroendocrinology; 2006 Feb; 31(2):216-25. PubMed ID: 16150550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test.
    Papadopoulos A; Ebrecht M; Roberts AD; Poon L; Rohleder N; Cleare AJ
    J Affect Disord; 2009 Jan; 112(1-3):289-94. PubMed ID: 18573538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of hypocortisolism in chronic fatigue syndrome.
    Nijhof SL; Rutten JM; Uiterwaal CS; Bleijenberg G; Kimpen JL; Putte EM
    Psychoneuroendocrinology; 2014 Apr; 42():199-206. PubMed ID: 24636516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary cortisol in panic: are males more vulnerable?
    van Duinen MA; Schruers KR; Jaegers E; Maes M; Griez EJ
    Neuro Endocrinol Lett; 2004 Oct; 25(5):386-90. PubMed ID: 15580175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders.
    Tak LM; Cleare AJ; Ormel J; Manoharan A; Kok IC; Wessely S; Rosmalen JG
    Biol Psychol; 2011 May; 87(2):183-94. PubMed ID: 21315796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.